The discovery that somatic cells can be reprogrammed to become induced pluripotent stem
(iPS) cells has ushered in a new and exciting era in regenerative medicine. Since the …

Over the last few years, the generation of induced pluripotent stem cells (iPSCs) from human
somatic cells has proved to be one of the most potentially useful discoveries in regenerative …

The methodology to create induced pluripotent stem cells (iPSCs) affords the opportunity to
generate cells specific to the individual providing the host tissue. However, existing methods …

Induced pluripotent stem cells (iPSCs) hold enormous potential for the development of
personalized in vitro disease models, genomic health analyses, and autologous cell …

The discovery of methods to convert somatic cells into induced pluripotent stem cells
(iPSCs) through expression of a small combination of transcription factors has raised the …

Background Generation of induced pluripotent stem cells (iPSCs) from human peripheral
blood provides a convenient and low-invasive way to obtain patient-specific iPSCs. The …

The invention of iPSC in 2006 has been heralded as a major breakthrough. Wenbin Deng
explains the enormous potential of these cells for research into human diseases and …

Recent advances in stem cell biology have transformed the understanding of cell physiology
and developmental biology such that it can now play a more prominent role in the clinical …

Induced pluripotent stem (iPS) cells can be generated by forced expression of four
pluripotency factors in somatic cells. This has received much attention in recent years since …

Human induced pluripotent stem cells (iPSCs) have emerged as an invaluable resource for
basic research, disease modeling, and drug discovery over recent years. Given the …